Regeneron and BAM have shared a long working relationship, partnering to create life science spaces catered to pharmaceutical research. Check out some of our work in the video above, and listen as Regeneron CEO Leonard Schleifer discusses risk and reward and what has brought them to where they are today.

View the full article at Forbes.com.

Thumbnail © Albert Vecerka | Esto